Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the acquisition of Oral Care
Mandate

Vinge advises Axcel in connection with the acquisition of Oral Care

July 14, 2022 Employment and Benefits Commercial Agreements EU, Competition and Regulatory IT, Telecommunications and Outsourcing M&A Corporate Crime & Compliance Real Estate and Construction

Vinge advises Axcel in connection with the acquisition of Oral Care, a leading dental care provider in Sweden and Norway.

Founded in Stockholm, Sweden, in 1989, Oral Care pioneered Swedish mobile dental care, which entails treatment of elderly and disabled patients in their own homes, typically nursing homes. In 2015, Oral Care leveraged its leading mobile practice to establish a clinic footprint in Sweden. Since then, the company has expanded its clinic network by acquiring and integrating well-performing clinics in Sweden and Norway. Oral Care currently operates 12 clinics in Sweden and two in Norway. Furthermore, Oral Care is Sweden’s largest private provider of mobile dental care, active in seven regions in central and southern Sweden.

The acquisition is subject to approval from applicable competition authority.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Elsie Nassar, Nando Basic and Ida Redander (M&A), Christoffer Nordin (Commercial Agreements, Regulatory and Permits), Mikael Ståhl, Linn Adelwald and Ellen Flygt (Banking and Financing), Frida Ställborn (Real Estate and Environmental), Julia Löfqvist (Compliance), Lina André (Employment), Nicklas Thorgerzon (IT and GDPR), Michael Montner and Ian Jonsson (Intellectual Property), Johan Wahlbom and Victoria Fredén (Merger filing) and Jessica Henning (Project and VDR Assistant).

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

 The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

 Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026